Jan 7 (Reuters) - The United Arab Emirates' drug regulator has recalled certain Nestle infant formula products after the company recalled specific batches over a potential toxin risk, the state news agency (WAM) reported on Wednesday.
The Emirates Drug Establishment said no illness or adverse events linked to the affected batches have been reported or confirmed, WAM added.
The Qatari ministry of public health has also warned consumers against using specific batches of Nestle infant formula products over suspected contamination with cereulide toxin, the Qatari state news agency reported.
Nestle said late on Monday it was recalling specific batches of its SMA infant formula and follow-on formula due to the potential presence of a toxin that could lead to nausea, vomiting and abdominal cramps.
(Reporting by Ahmed Tolba and Yomna Ehab in Cairo; Editing by Chris Reese and David Gregorio)
LATEST POSTS
Vote in favor of your Number one kind of juice- Turkey's Erdogan denounces Israel-Greece-Cyprus trilateral summit, affirms support for Gaza
- Etymological Investigation Disclosed: A Survey of \Dominating New Tongues\ Language Learning Application
- Understanding the Rudiments of Tree Administrations
- Kenmore East reacts to their best overall delegation award at WNY Model United Nations General Assembly competition
- The Best 15 Applications for Efficiency and Association
- These Are the Journalists Israel Has Killed Since the Start of the Iran War
- Little Italy Mercato brings fresh food and community to downtown San Diego
- Step by step instructions to Pick an Incineration Urn: Variables to Consider
